As drug manufacturing scaled up, most medications became commercially available, but compounding remained important for specific situations
It activates AMPK, an enzyme that promotes fat breakdown and increases energy use
Q: Please explain your Action Plans
Patients should contact their GP or diabetes care team if they experience: Severe or persistent abdominal pain , particularly if localised to the upper abdomen, which may indicate pancreatitis (a rare but serious adverse effect) Persistent vomiting that prevents adequate fluid or food intake, risking dehydration Signs of dehydration , including reduced urine output, dizziness, dry mouth, or confusion Severe diarrhoea lasting more than 48 hours Unexplained weight loss beyond what is expected from the medication's therapeutic effect Symptoms of gastroparesis (severe delayed gastric emptying), such as early satiety, persistent nausea, vomiting undigested food, or severe bloating Right upper quadrant pain, fever, jaundice, pale stools or dark urine , which may indicate gallbladder disease (a known risk with GLP-1 receptor agonists and weight loss) [5] [11] Markedly reduced urine output , which may indicate acute kidney injury from dehydration Immediate medical attention (999 or A&E) is required if: Severe, unrelenting abdominal pain develops, especially if radiating to the back There is persistent vomiting with inability to keep down fluids Signs of acute pancreatitis appear (severe upper abdominal pain, fever, rapid pulse) If pancreatitis is suspected, semaglutide should be stopped immediately and urgent medical assessment sought
This stepwise approach helps the body adjust and reduces the likelihood of adverse effects
Zamora-Len P
